Inhibition of fatty acid synthase expression by 1α,25-dihydroxyvitamin D3 in prostate cancer cells
- 31 May 2003
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 85 (1), 1-8
- https://doi.org/10.1016/s0960-0760(03)00142-0
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Antiproliferative Action of Vitamin DPublished by Elsevier ,2002
- Increased fatty acid synthase as a therapeutic target in androgen‐independent prostate cancer progressionThe Prostate, 2001
- 1 ,25-Dihydroxyvitamin D3 Inhibits Prostate Cancer Cell Growth by Androgen-Dependent and Androgen-Independent MechanismsEndocrinology, 2000
- Induction of Androgen Receptor by 1 ,25-Dihydroxyvitamin D3 and 9-cis Retinoic Acid in LNCaP Human Prostate Cancer CellsEndocrinology, 1999
- Expression of Fatty Acid Synthase Is Closely Linked to Proliferation and Stromal Decidualization in Cycling EndometriumInternational Journal of Gynecological Pathology, 1997
- The prognostic value of oncogenic antigen 519 (OA‐519) expression and proliferative activity detected by antibody MIB‐I in node‐negative breast cancerThe Journal of Pathology, 1995
- OA-519 (fatty acid synthase) as an independent predictor of pathologic stage in adenocarcinoma of the prostateUrology, 1995
- Synthetic progestins induce proliferation of breast tumor cell lines via the progesterone or estrogen receptorMolecular and Cellular Endocrinology, 1994
- The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogensThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- The effect of histidine ammonia-lyase on some murine tumoursLeukemia Research, 1983